---
- :identifier: C66767
  :notation: ACN
  :preferred_term: CDISC SDTM Action Taken with Study Treatment Terminology
  :synonym: Action Taken with Study Treatment
  :extensible: false
  :definition: The reason that changes were made to the therapy under study. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzY2NzY3L1Y0I0M2Njc2Nw==
  :tags: SDTM
- :identifier: C66768
  :notation: OUT
  :preferred_term: CDISC SDTM Adverse Event Outcome Terminology
  :synonym: Outcome of Event
  :extensible: false
  :definition: A condition or event that is attributed to the adverse event and is
    the result or conclusion of the adverse event. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzY2NzY4L1Y0I0M2Njc2OA==
  :tags: SDTM
- :identifier: C66780
  :notation: AGESPAN
  :preferred_term: CDISC SDTM Age GroupTerminology
  :synonym: Age Span
  :extensible: true
  :definition: Subgroups of populations based on age. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzY2NzgwL1Y0I0M2Njc4MA==
  :tags: SDTM
- :identifier: C66781
  :notation: AGEU
  :preferred_term: CDISC SDTM Age UnitTerminology
  :synonym: Age Unit
  :extensible: false
  :definition: Those units of time that are routinely used to express the age of a
    person. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzY2NzgxL1Y0I0M2Njc4MQ==
  :tags: SDTM
- :identifier: C66783
  :notation: SOC
  :preferred_term: CDISC SDTM System Organ Class Terminology
  :synonym: CDISC System Organ Class
  :extensible: false
  :definition: Terms at the highest level of the CDISC system organ class terminology.
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzY2NzgzL1Y0I0M2Njc4Mw==
  :tags: SDTM
- :identifier: C66784
  :notation: TOXGR
  :preferred_term: CDISC SDTM CommonTerminology Criteria for Adverse Event Grade Terminology
  :synonym: Common Terminology Criteria for Adverse Events
  :extensible: false
  :definition: A standard terminology developed to report adverse events occurring
    in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE)
    are used in study adverse event summaries and Investigational New Drug reports
    to the Food and Drug Administration.  The CTCAE contain a grading scale for each
    adverse event term representing the severity of the event. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzY2Nzg0L1Y0I0M2Njc4NA==
  :tags: SDTM
- :identifier: C66785
  :notation: TCNTRL
  :preferred_term: CDISC SDTM Control Type Terminology
  :synonym: Control Type; Type of Control
  :extensible: true
  :definition: Comparator against which the study treatment is evaluated (e.g., concurrent
    (placebo, no treatment, dose-response, active), external (historical, published
    literature).
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzY2Nzg1L1Y0I0M2Njc4NQ==
  :tags: SDTM
- :identifier: C66786
  :notation: COUNTRY
  :preferred_term: CDISC SDTM Country Terminology
  :synonym: Country
  :extensible: false
  :definition: A collective generic term that refers here to a wide variety of dependencies,
    areas of special sovereignty, uninhabited islands, and other entities in addition
    to the traditional countries or independent states. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzY2Nzg2L1Y0I0M2Njc4Ng==
  :tags: SDTM
- :identifier: C66787
  :notation: TDIGRP
  :preferred_term: CDISC SDTM Diagnosis Group Terminology
  :synonym: Diagnosis Group
  :extensible: true
  :definition: A grouping of individuals on the basis of a shared procedure or disease,
    or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with
    renal cell cancer).  Standardized naming systems are available that define the
    groups within which a subject should be placed. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzY2Nzg3L1Y0I0M2Njc4Nw==
  :tags: SDTM
- :identifier: C66797
  :notation: IECAT
  :preferred_term: CDISC SDTM Category of Inclusion And Or ExclusionTerminology
  :synonym: Category for Inclusion/Exclusion
  :extensible: false
  :definition: A collection of criteria on which subjects are evaluated and that must
    be met by all study subjects. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzY2Nzk3L1Y0I0M2Njc5Nw==
  :tags: SDTM
